Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ImmunityBio (IBRX) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for ImmunityBio (IBRX) over the last 11 years, with Q3 2025 value amounting to $289000.0.

  • ImmunityBio's Other Non Operating Income fell 8209.42% to $289000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.0 million, marking a year-over-year decrease of 33469.24%. This contributed to the annual value of $13.5 million for FY2024, which is 70625.28% up from last year.
  • Per ImmunityBio's latest filing, its Other Non Operating Income stood at $289000.0 for Q3 2025, which was down 8209.42% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, ImmunityBio's Other Non Operating Income ranged from a high of $21.2 million in Q2 2024 and a low of -$42.6 million during Q1 2025
  • Over the past 5 years, ImmunityBio's median Other Non Operating Income value was -$28000.0 (recorded in 2023), while the average stood at -$1.6 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first crashed by 2682500.0% in 2023, then skyrocketed by 7579285.71% in 2024.
  • ImmunityBio's Other Non Operating Income (Quarter) stood at -$59000.0 in 2021, then tumbled by 1464.41% to -$923000.0 in 2022, then skyrocketed by 92.31% to -$71000.0 in 2023, then plummeted by 9205.63% to -$6.6 million in 2024, then soared by 104.37% to $289000.0 in 2025.
  • Its Other Non Operating Income stands at $289000.0 for Q3 2025, versus $1.9 million for Q2 2025 and -$42.6 million for Q1 2025.